Bleakley Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.2M Buy
131,874
+7,534
+6% +$1.75M 0.5% 44
2025
Q4
$25.7M Sell
124,340
-10,537
-8% -$2.08M 0.45% 45
2025
Q3
$25M Buy
134,877
+22,514
+20% +$3.86M 0.58% 37
2025
Q2
$17.2M Buy
112,363
+1,543
+1% +$237K 0.44% 45
2025
Q1
$18.4M Buy
110,820
+10,025
+10% +$1.57M 0.59% 32
2024
Q4
$14.6M Sell
100,795
-7,509
-7% -$1.16M 0.44% 38
2024
Q3
$17.6M Buy
108,304
+2,864
+3% +$456K 0.53% 31
2024
Q2
$15.4M Sell
105,440
-5,913
-5% -$879K 0.44% 38
2024
Q1
$17.6M Sell
111,353
-102
-0.1% -$16.2K 0.51% 33
2023
Q4
$17.5M Sell
111,455
-1,330
-1% -$204K 0.56% 31
2023
Q3
$17.6M Sell
112,785
-10,188
-8% -$1.68M 0.62% 28
2023
Q2
$20.4M Buy
122,973
+11,313
+10% +$1.83M 0.64% 29
2023
Q1
$17.3M Sell
111,660
-4,955
-4% -$800K 0.58% 31
2022
Q4
$20.6M Buy
+116,615
New +$20.1M 0.74% 23

Other funds holding JNJ

Bleakley Financial Group's JNJ Position: Q1 2026 in Review

Bleakley Financial Group increased its Johnson & Johnson (JNJ) stake by 6.1% in Q1 2026, buying an estimated $1.75M and bringing the position to 131,874 shares worth $32.2M. The position accounts for 0.5% of the portfolio, ranked #44.

Bleakley Financial Group first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Bleakley Financial Group held 131,874 shares of Johnson & Johnson worth $32.2M as of Q1 2026.
  • Bleakley Financial Group bought 7,534 Johnson & Johnson shares in Q1 2026, an estimated $1.75M.
  • Johnson & Johnson made up 0.5% of Bleakley Financial Group's portfolio in Q1 2026, its #44 holding.
  • Bleakley Financial Group first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bleakley Financial Group's 13F filing for Q1 2026, filed 4 May 2026.